Bank of Montreal’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bank of Montreal’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,595	Closed	-$2.31M	–	4380
2023 Q2	$2.31M	Buy	+22,595	New	+$2.14M	﹤0.01%	1731
2021 Q2	–	Sell	-545	Closed	-$51K	–	5208
2021 Q1	$51K	Buy	545 +242	+80%	+$28.2K	﹤0.01%	3689
2020 Q4	$38K	Buy	303 +84	+38%	+$11K	﹤0.01%	4092
2020 Q3	$24K	Sell	219 -134	-38%	-$16.7K	﹤0.01%	3768
2020 Q2	$55K	Sell	353 -67	-16%	-$10.2K	﹤0.01%	3406
2020 Q1	$57K	Sell	420 -2,537	-86%	-$490K	﹤0.01%	2841
2019 Q4	$604K	Buy	2,957 +1,123	+61%	+$205K	﹤0.01%	2563
2019 Q3	$148K	Buy	1,834 +5	+0.3%	+$424	﹤0.01%	3091
2019 Q2	$173K	Buy	1,829 +1,759	+2,513%	+$152K	﹤0.01%	3010
2019 Q1	$6K	Sell	70 -263	-79%	-$21.8K	﹤0.01%	4007
2018 Q4	$19K	Buy	333 +204	+158%	+$12.5K	﹤0.01%	3673
2018 Q3	$11K	Buy	129 +16	+14%	+$1.13K	﹤0.01%	3910
2018 Q2	$4K	Buy	+113	New	+$3.44K	﹤0.01%	4203
2016 Q3	–	Sell	-5,162	Closed	-$102K	–	4244
2016 Q2	$102K	Buy	+5,162	New	+$100K	﹤0.01%	2794

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of Montreal's RETA Position: Q3 2023 in Review

Bank of Montreal sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 22,595 shares — an estimated $2.31M sold.

Bank of Montreal first reported a position in RETA in Q2 2016 and held it in 14 quarters. The position peaked at $2.31M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Bank of Montreal reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of Montreal sold 22,595 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.31M.
Bank of Montreal first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and held it in 14 quarters.
Bank of Montreal's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $2.31M in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.